Loading…

AT2 Receptor Deficiency Attenuates Adipocyte Differentiation and Decreases Adipocyte Number in Atherosclerotic Mice

Background Previous reports indicated that blockade of AT1 receptor stimulation attenuated adipocyte dysfunction. However, the effects of AT2 receptor stimulation on adipose tissue were not yet clear. In the present study, we examined the adipose tissue dysfunction in atherosclerotic apolipoprotein...

Full description

Saved in:
Bibliographic Details
Published in:American journal of hypertension 2009-07, Vol.22 (7), p.784-791
Main Authors: Iwai, Masaru, Tomono, Yumiko, Inaba, Shinji, Kanno, Harumi, Senba, Izumi, Mogi, Masaki, Horiuchi, Masatsugu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c329t-d98586b0eca93245bf10c9736400fee547a2312e47cce973cfe43034ffffbb103
cites cdi_FETCH-LOGICAL-c329t-d98586b0eca93245bf10c9736400fee547a2312e47cce973cfe43034ffffbb103
container_end_page 791
container_issue 7
container_start_page 784
container_title American journal of hypertension
container_volume 22
creator Iwai, Masaru
Tomono, Yumiko
Inaba, Shinji
Kanno, Harumi
Senba, Izumi
Mogi, Masaki
Horiuchi, Masatsugu
description Background Previous reports indicated that blockade of AT1 receptor stimulation attenuated adipocyte dysfunction. However, the effects of AT2 receptor stimulation on adipose tissue were not yet clear. In the present study, we examined the adipose tissue dysfunction in atherosclerotic apolipoprotein E knockout (ApoEKO) mice with AT2 receptor deficiency. Methods Male ApoEKO and AT2 receptor/ApoE knockout (AT2/ApoEKO) mice at 6 weeks of age were treated with a normal diet or a high-cholesterol diet (HCD: 1.25% cholesterol). Markers for adipocyte differentiation and inflammation in adipose tissue were assayed with real-time reverse-transcription-PCR and western blot. Results Compared with ApoEKO mice, AT2/ApoEKO mice with a normal diet showed only a decrease in expression of adiponectin and CCAAT/enhancer binding protein δ (C/EBPδ) in epididymal adipose tissue without changes in body weight, adipose tissue weight, and adipocyte number even at 6 months of age. After HCD for 4 weeks, the weight of both epididymal and retroperitoneal adipose tissue in AT2/ApoEKO mice was greater than that in ApoEKO mice without a change in body weight. Plasma concentrations of cholesterol and fatty acids were higher in AT2/ApoEKO mice than in ApoEKO mice. In adipose tissue of AT2/ApoEKO mice, the adipocyte number was decreased and the expression of peroxisome proliferator–activated receptor γ (PPARγ), C/EBPα, and aP2 was lower than that in ApoEKO mice, in association with an increase in nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity. Conclusions These results suggest that AT2 receptor stimulation in adipose tissue is involved in the improvement of adipocyte differentiation and adipose tissue dysfunction in atherosclerotic model.
doi_str_mv 10.1038/ajh.2009.85
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67394382</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1038/ajh.2009.85</oup_id><sourcerecordid>2709944751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c329t-d98586b0eca93245bf10c9736400fee547a2312e47cce973cfe43034ffffbb103</originalsourceid><addsrcrecordid>eNqF0c2LEzEUAPAgiltXT95lQPQiU_M1k5lj2aordFeQ-oGXkHl9YVOnmdkkA_a_N6WlohdzSCD88l7ee4Q8Z3TOqGjemu3dnFPazpvqAZmxVrJScV49JDPatFWpaM0uyJMYt5RSWdfsMbnISErOxYzExZoXnxFwTEMolmgdOPSwLxYpoZ9MwlgsNm4cYJ-wWDprMaBPziQ3-ML4TX4DAU38y91Ouw5D4XwOc4dhiNDnPTkobhzgU_LImj7is9N5Sb68f7e-ui5Xnz58vFqsShC8TeWmbaqm7iiCaQWXVWcZhVaJWlJqESupDBeMo1QAmO_BohRUSJtX1-XWXJLXx7hjGO4njEnvXATse-NxmKKulWilaHiGL_-B22EKPv9NM8plIyQVdVZvjgpyQTGg1WNwOxP2GenDJHSehD5MQjdV1i9OMaduh5s_9tT6DF6dgIlgehuMBxfPjjMlFM25z1UM0_ifjOURupjw15ma8PNQqar09fcfen27XK7qm2_6q_gNfaisyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1024834036</pqid></control><display><type>article</type><title>AT2 Receptor Deficiency Attenuates Adipocyte Differentiation and Decreases Adipocyte Number in Atherosclerotic Mice</title><source>Oxford Journals Online</source><creator>Iwai, Masaru ; Tomono, Yumiko ; Inaba, Shinji ; Kanno, Harumi ; Senba, Izumi ; Mogi, Masaki ; Horiuchi, Masatsugu</creator><creatorcontrib>Iwai, Masaru ; Tomono, Yumiko ; Inaba, Shinji ; Kanno, Harumi ; Senba, Izumi ; Mogi, Masaki ; Horiuchi, Masatsugu</creatorcontrib><description>Background Previous reports indicated that blockade of AT1 receptor stimulation attenuated adipocyte dysfunction. However, the effects of AT2 receptor stimulation on adipose tissue were not yet clear. In the present study, we examined the adipose tissue dysfunction in atherosclerotic apolipoprotein E knockout (ApoEKO) mice with AT2 receptor deficiency. Methods Male ApoEKO and AT2 receptor/ApoE knockout (AT2/ApoEKO) mice at 6 weeks of age were treated with a normal diet or a high-cholesterol diet (HCD: 1.25% cholesterol). Markers for adipocyte differentiation and inflammation in adipose tissue were assayed with real-time reverse-transcription-PCR and western blot. Results Compared with ApoEKO mice, AT2/ApoEKO mice with a normal diet showed only a decrease in expression of adiponectin and CCAAT/enhancer binding protein δ (C/EBPδ) in epididymal adipose tissue without changes in body weight, adipose tissue weight, and adipocyte number even at 6 months of age. After HCD for 4 weeks, the weight of both epididymal and retroperitoneal adipose tissue in AT2/ApoEKO mice was greater than that in ApoEKO mice without a change in body weight. Plasma concentrations of cholesterol and fatty acids were higher in AT2/ApoEKO mice than in ApoEKO mice. In adipose tissue of AT2/ApoEKO mice, the adipocyte number was decreased and the expression of peroxisome proliferator–activated receptor γ (PPARγ), C/EBPα, and aP2 was lower than that in ApoEKO mice, in association with an increase in nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity. Conclusions These results suggest that AT2 receptor stimulation in adipose tissue is involved in the improvement of adipocyte differentiation and adipose tissue dysfunction in atherosclerotic model.</description><identifier>ISSN: 0895-7061</identifier><identifier>EISSN: 1941-7225</identifier><identifier>EISSN: 1879-1905</identifier><identifier>DOI: 10.1038/ajh.2009.85</identifier><identifier>PMID: 19444223</identifier><identifier>CODEN: AJHYE6</identifier><language>eng</language><publisher>Basingstoke: Oxford University Press</publisher><subject>Adipocytes - physiology ; Adipose Tissue - drug effects ; Adipose Tissue - pathology ; Angiotensin II Type 1 Receptor Blockers - pharmacology ; Angiotensin II Type 2 Receptor Blockers ; Animals ; Apolipoproteins E - genetics ; Arterial hypertension. Arterial hypotension ; Atherosclerosis - pathology ; Atherosclerosis - physiopathology ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cell Count ; Cell Differentiation - physiology ; Cholesterol, Dietary - administration &amp; dosage ; Clinical manifestations. Epidemiology. Investigative techniques. Etiology ; Insulin Receptor Substrate Proteins - metabolism ; Male ; Medical sciences ; Mice ; Mice, Knockout ; NADPH Oxidases - metabolism ; Receptor, Angiotensin, Type 2 - deficiency ; Receptor, Angiotensin, Type 2 - physiology ; Tetrazoles - pharmacology ; Valine - analogs &amp; derivatives ; Valine - pharmacology ; Valsartan</subject><ispartof>American journal of hypertension, 2009-07, Vol.22 (7), p.784-791</ispartof><rights>American Journal of Hypertension, Ltd. © 2009 by the American Journal of Hypertension, Ltd. 2009</rights><rights>2009 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Jul 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c329t-d98586b0eca93245bf10c9736400fee547a2312e47cce973cfe43034ffffbb103</citedby><cites>FETCH-LOGICAL-c329t-d98586b0eca93245bf10c9736400fee547a2312e47cce973cfe43034ffffbb103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21737048$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19444223$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iwai, Masaru</creatorcontrib><creatorcontrib>Tomono, Yumiko</creatorcontrib><creatorcontrib>Inaba, Shinji</creatorcontrib><creatorcontrib>Kanno, Harumi</creatorcontrib><creatorcontrib>Senba, Izumi</creatorcontrib><creatorcontrib>Mogi, Masaki</creatorcontrib><creatorcontrib>Horiuchi, Masatsugu</creatorcontrib><title>AT2 Receptor Deficiency Attenuates Adipocyte Differentiation and Decreases Adipocyte Number in Atherosclerotic Mice</title><title>American journal of hypertension</title><addtitle>AJH</addtitle><description>Background Previous reports indicated that blockade of AT1 receptor stimulation attenuated adipocyte dysfunction. However, the effects of AT2 receptor stimulation on adipose tissue were not yet clear. In the present study, we examined the adipose tissue dysfunction in atherosclerotic apolipoprotein E knockout (ApoEKO) mice with AT2 receptor deficiency. Methods Male ApoEKO and AT2 receptor/ApoE knockout (AT2/ApoEKO) mice at 6 weeks of age were treated with a normal diet or a high-cholesterol diet (HCD: 1.25% cholesterol). Markers for adipocyte differentiation and inflammation in adipose tissue were assayed with real-time reverse-transcription-PCR and western blot. Results Compared with ApoEKO mice, AT2/ApoEKO mice with a normal diet showed only a decrease in expression of adiponectin and CCAAT/enhancer binding protein δ (C/EBPδ) in epididymal adipose tissue without changes in body weight, adipose tissue weight, and adipocyte number even at 6 months of age. After HCD for 4 weeks, the weight of both epididymal and retroperitoneal adipose tissue in AT2/ApoEKO mice was greater than that in ApoEKO mice without a change in body weight. Plasma concentrations of cholesterol and fatty acids were higher in AT2/ApoEKO mice than in ApoEKO mice. In adipose tissue of AT2/ApoEKO mice, the adipocyte number was decreased and the expression of peroxisome proliferator–activated receptor γ (PPARγ), C/EBPα, and aP2 was lower than that in ApoEKO mice, in association with an increase in nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity. Conclusions These results suggest that AT2 receptor stimulation in adipose tissue is involved in the improvement of adipocyte differentiation and adipose tissue dysfunction in atherosclerotic model.</description><subject>Adipocytes - physiology</subject><subject>Adipose Tissue - drug effects</subject><subject>Adipose Tissue - pathology</subject><subject>Angiotensin II Type 1 Receptor Blockers - pharmacology</subject><subject>Angiotensin II Type 2 Receptor Blockers</subject><subject>Animals</subject><subject>Apolipoproteins E - genetics</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Atherosclerosis - pathology</subject><subject>Atherosclerosis - physiopathology</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cell Count</subject><subject>Cell Differentiation - physiology</subject><subject>Cholesterol, Dietary - administration &amp; dosage</subject><subject>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</subject><subject>Insulin Receptor Substrate Proteins - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>NADPH Oxidases - metabolism</subject><subject>Receptor, Angiotensin, Type 2 - deficiency</subject><subject>Receptor, Angiotensin, Type 2 - physiology</subject><subject>Tetrazoles - pharmacology</subject><subject>Valine - analogs &amp; derivatives</subject><subject>Valine - pharmacology</subject><subject>Valsartan</subject><issn>0895-7061</issn><issn>1941-7225</issn><issn>1879-1905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqF0c2LEzEUAPAgiltXT95lQPQiU_M1k5lj2aordFeQ-oGXkHl9YVOnmdkkA_a_N6WlohdzSCD88l7ee4Q8Z3TOqGjemu3dnFPazpvqAZmxVrJScV49JDPatFWpaM0uyJMYt5RSWdfsMbnISErOxYzExZoXnxFwTEMolmgdOPSwLxYpoZ9MwlgsNm4cYJ-wWDprMaBPziQ3-ML4TX4DAU38y91Ouw5D4XwOc4dhiNDnPTkobhzgU_LImj7is9N5Sb68f7e-ui5Xnz58vFqsShC8TeWmbaqm7iiCaQWXVWcZhVaJWlJqESupDBeMo1QAmO_BohRUSJtX1-XWXJLXx7hjGO4njEnvXATse-NxmKKulWilaHiGL_-B22EKPv9NM8plIyQVdVZvjgpyQTGg1WNwOxP2GenDJHSehD5MQjdV1i9OMaduh5s_9tT6DF6dgIlgehuMBxfPjjMlFM25z1UM0_ifjOURupjw15ma8PNQqar09fcfen27XK7qm2_6q_gNfaisyQ</recordid><startdate>200907</startdate><enddate>200907</enddate><creator>Iwai, Masaru</creator><creator>Tomono, Yumiko</creator><creator>Inaba, Shinji</creator><creator>Kanno, Harumi</creator><creator>Senba, Izumi</creator><creator>Mogi, Masaki</creator><creator>Horiuchi, Masatsugu</creator><general>Oxford University Press</general><general>Nature Publishing Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>200907</creationdate><title>AT2 Receptor Deficiency Attenuates Adipocyte Differentiation and Decreases Adipocyte Number in Atherosclerotic Mice</title><author>Iwai, Masaru ; Tomono, Yumiko ; Inaba, Shinji ; Kanno, Harumi ; Senba, Izumi ; Mogi, Masaki ; Horiuchi, Masatsugu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c329t-d98586b0eca93245bf10c9736400fee547a2312e47cce973cfe43034ffffbb103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adipocytes - physiology</topic><topic>Adipose Tissue - drug effects</topic><topic>Adipose Tissue - pathology</topic><topic>Angiotensin II Type 1 Receptor Blockers - pharmacology</topic><topic>Angiotensin II Type 2 Receptor Blockers</topic><topic>Animals</topic><topic>Apolipoproteins E - genetics</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Atherosclerosis - pathology</topic><topic>Atherosclerosis - physiopathology</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cell Count</topic><topic>Cell Differentiation - physiology</topic><topic>Cholesterol, Dietary - administration &amp; dosage</topic><topic>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</topic><topic>Insulin Receptor Substrate Proteins - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>NADPH Oxidases - metabolism</topic><topic>Receptor, Angiotensin, Type 2 - deficiency</topic><topic>Receptor, Angiotensin, Type 2 - physiology</topic><topic>Tetrazoles - pharmacology</topic><topic>Valine - analogs &amp; derivatives</topic><topic>Valine - pharmacology</topic><topic>Valsartan</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iwai, Masaru</creatorcontrib><creatorcontrib>Tomono, Yumiko</creatorcontrib><creatorcontrib>Inaba, Shinji</creatorcontrib><creatorcontrib>Kanno, Harumi</creatorcontrib><creatorcontrib>Senba, Izumi</creatorcontrib><creatorcontrib>Mogi, Masaki</creatorcontrib><creatorcontrib>Horiuchi, Masatsugu</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iwai, Masaru</au><au>Tomono, Yumiko</au><au>Inaba, Shinji</au><au>Kanno, Harumi</au><au>Senba, Izumi</au><au>Mogi, Masaki</au><au>Horiuchi, Masatsugu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AT2 Receptor Deficiency Attenuates Adipocyte Differentiation and Decreases Adipocyte Number in Atherosclerotic Mice</atitle><jtitle>American journal of hypertension</jtitle><addtitle>AJH</addtitle><date>2009-07</date><risdate>2009</risdate><volume>22</volume><issue>7</issue><spage>784</spage><epage>791</epage><pages>784-791</pages><issn>0895-7061</issn><eissn>1941-7225</eissn><eissn>1879-1905</eissn><coden>AJHYE6</coden><abstract>Background Previous reports indicated that blockade of AT1 receptor stimulation attenuated adipocyte dysfunction. However, the effects of AT2 receptor stimulation on adipose tissue were not yet clear. In the present study, we examined the adipose tissue dysfunction in atherosclerotic apolipoprotein E knockout (ApoEKO) mice with AT2 receptor deficiency. Methods Male ApoEKO and AT2 receptor/ApoE knockout (AT2/ApoEKO) mice at 6 weeks of age were treated with a normal diet or a high-cholesterol diet (HCD: 1.25% cholesterol). Markers for adipocyte differentiation and inflammation in adipose tissue were assayed with real-time reverse-transcription-PCR and western blot. Results Compared with ApoEKO mice, AT2/ApoEKO mice with a normal diet showed only a decrease in expression of adiponectin and CCAAT/enhancer binding protein δ (C/EBPδ) in epididymal adipose tissue without changes in body weight, adipose tissue weight, and adipocyte number even at 6 months of age. After HCD for 4 weeks, the weight of both epididymal and retroperitoneal adipose tissue in AT2/ApoEKO mice was greater than that in ApoEKO mice without a change in body weight. Plasma concentrations of cholesterol and fatty acids were higher in AT2/ApoEKO mice than in ApoEKO mice. In adipose tissue of AT2/ApoEKO mice, the adipocyte number was decreased and the expression of peroxisome proliferator–activated receptor γ (PPARγ), C/EBPα, and aP2 was lower than that in ApoEKO mice, in association with an increase in nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity. Conclusions These results suggest that AT2 receptor stimulation in adipose tissue is involved in the improvement of adipocyte differentiation and adipose tissue dysfunction in atherosclerotic model.</abstract><cop>Basingstoke</cop><pub>Oxford University Press</pub><pmid>19444223</pmid><doi>10.1038/ajh.2009.85</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0895-7061
ispartof American journal of hypertension, 2009-07, Vol.22 (7), p.784-791
issn 0895-7061
1941-7225
1879-1905
language eng
recordid cdi_proquest_miscellaneous_67394382
source Oxford Journals Online
subjects Adipocytes - physiology
Adipose Tissue - drug effects
Adipose Tissue - pathology
Angiotensin II Type 1 Receptor Blockers - pharmacology
Angiotensin II Type 2 Receptor Blockers
Animals
Apolipoproteins E - genetics
Arterial hypertension. Arterial hypotension
Atherosclerosis - pathology
Atherosclerosis - physiopathology
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cell Count
Cell Differentiation - physiology
Cholesterol, Dietary - administration & dosage
Clinical manifestations. Epidemiology. Investigative techniques. Etiology
Insulin Receptor Substrate Proteins - metabolism
Male
Medical sciences
Mice
Mice, Knockout
NADPH Oxidases - metabolism
Receptor, Angiotensin, Type 2 - deficiency
Receptor, Angiotensin, Type 2 - physiology
Tetrazoles - pharmacology
Valine - analogs & derivatives
Valine - pharmacology
Valsartan
title AT2 Receptor Deficiency Attenuates Adipocyte Differentiation and Decreases Adipocyte Number in Atherosclerotic Mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T19%3A07%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AT2%20Receptor%20Deficiency%20Attenuates%20Adipocyte%20Differentiation%20and%20Decreases%20Adipocyte%20Number%20in%20Atherosclerotic%20Mice&rft.jtitle=American%20journal%20of%20hypertension&rft.au=Iwai,%20Masaru&rft.date=2009-07&rft.volume=22&rft.issue=7&rft.spage=784&rft.epage=791&rft.pages=784-791&rft.issn=0895-7061&rft.eissn=1941-7225&rft.coden=AJHYE6&rft_id=info:doi/10.1038/ajh.2009.85&rft_dat=%3Cproquest_cross%3E2709944751%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c329t-d98586b0eca93245bf10c9736400fee547a2312e47cce973cfe43034ffffbb103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1024834036&rft_id=info:pmid/19444223&rft_oup_id=10.1038/ajh.2009.85&rfr_iscdi=true